In this edition

–  Characteristics, management and outcomes in congestive HF
–  Dapagliflozin and mode of death in HF with improved EF
–  Changes in walking speed and handgrip strength after HF hospitalisation
–  Vericiguat vs. sacubitril-valsartan for HFREF
–  Sex disparities in guideline-directed medical therapy for HF
–  Association of β-blocker use with exercise capacity in HFPEF
–  Sacubitril-valsartan in hospitalised decompensated HF
–  BP, hypertension and HF risk
–  Prevalence of subclinical AF in HFPEF
–  Treatment effect of intravenous iron in iron-deficient HF

Download the Heart Failure Research Review Issue 85, with commentary by Prof Andrew Coats